VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study

Affiliations

• ¹ Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway. jaknoe@ous-hf.no.
• ² Institute of Clinical Medicine, University of Oslo, Oslo, Norway. jaknoe@ous-hf.no.
• ³ KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway. jaknoe@ous-hf.no.
• ⁴ Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.
• ⁵ Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
• ⁶ KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway.
• ⁷ Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway.
• ⁸ Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
• ⁹ Department of Hematology, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway.
• ¹⁰ Department of Hematology, University Hospital of North Norway, Tromsø, Norway.
• ¹¹ Institute of Clinical Medicine, The Arctic University of Norway, UiT, Tromsø, Norway.
• ¹² Department of Hematology, Oslo University Hospital, Oslo, Norway.
• ¹³ Clinic for Medicine, Haukeland University Hospital, Bergen, Norway.